Why All GLP-1 Drugs Face Lawsuits Despite their differences in active ingredients, manufacturers, and mechanisms, all GLP-1 medications share one critical characteristic that makes them dangerous : The Common Mechanism: Delayed Gastric Emptying Normal Digestion: You eat food Your stomach churns and breaks it down (1-2 hours) Partially digested food moves into the small intestine Nutrients are absorbed Waste continues to the colon On GLP-1 Medications: You eat food The drug dramatically slows stomach muscle contractions Food sits in the stomach for many hours (or days) Delayed movement into small intestine Prolonged fullness leads to appetite suppression and weight loss For Most Patients: This causes temporary fullness and reduced appetite - the intended effect
(131) proved the neuroprotective efficacy of intracerebroventricular injection (i.c.v.) of Ex-4 exerted after transient ischemia/reperfusion in rats and first suggested that Ex-4 played a neuroprotective role probably by stimulating the GLP-1R/-endorphin signal pathway in hippocampal microglia (76)
While our meta-analysis demonstrated robust protective associations between GLP-1R activation and psychiatric conditions such as schizophrenia and anxiety disorders, sensitivity analyses revealed broader CIs that occasionally crossed the null
[DOI] [PubMed] [Google Scholar] 22.Yamamoto BK, Bankson MG
I've also noticed a warmth around my belly
Between 2014 and now, prescriptions for these GLP-1 drugs have increased a whopping 300 percent
